Robert Axon to Medication Adherence
This is a "connection" page, showing publications Robert Axon has written about Medication Adherence.
Connection Strength
0.860
-
Comorbid depression is differentially associated with longitudinal medication nonadherence by race/ethnicity in patients with type 2 diabetes. Medicine (Baltimore). 2016 Jun; 95(25):e3983.
Score: 0.421
-
The Impact of Dual Health Care System Use for Obtaining Prescription Medications on Nonadherence in Veterans With Type 2 Diabetes. Ann Pharmacother. 2019 07; 53(7):675-682.
Score: 0.127
-
Investigating the Potential for Bias When Using a Widely Accepted Medication Adherence Measure to Predict Mortality. Pharmacotherapy. 2018 11; 38(11):1086-1094.
Score: 0.123
-
Medication nonadherence in diabetes: longitudinal effects on costs and potential cost savings from improvement. Diabetes Care. 2012 Dec; 35(12):2533-9.
Score: 0.081
-
Regional, Geographic, and Ethnic Differences in Medication Adherence Among Adults with Type 2 Diabetes. Ann Pharmacother. 2011 Feb; 45(2):169-78.
Score: 0.073
-
Geographic and Racial/Ethnic Variation in Glycemic Control and Treatment in a National Sample of Veterans With Diabetes. Diabetes Care. 2020 10; 43(10):2460-2468.
Score: 0.035